Top 5 Medical VC Funds & Investors in Philippines (June 2026)

Portfolio highlights

• Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
• Factorymaker — Factorymaker designs and analyzes sustainable, cost-efficient industrial layout and building proposals, guiding you through informed decisions at early design stage
• VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.

Portfolio highlights

• World View Enterprises — World View sets the standard for stratospheric exploration via remote sensing, C4ISR and asset monitoring via stratospheric balloons, along with future space tourism and research and education offerings.
• RayGen — We're powering the future with low cost, high efficiency solar power technology and renewable energy storage. Contact us for more details today.
• Conflux Technology — Conflux Technology is a new generation of heat exchangers made by metal additive manufacturing (3D printing).

Portfolio highlights

• Playdex — Playdex is an NFT gaming rental marketplace that seamlessly connects gamers, guilds, and NFT owners.
• STAT — STAT offers quick, wide range of meds & convenient online medicine delivery. We are revolutionizing the way Filipinos purchase their medicine needs. We have delivered 1300+ orders with $69k revenue since we started in 2021 with a vision of dominating the $16.5B pharma market of PH.
• VAI Analytics — We build the platforms that power Philippine brokerages.

Portfolio highlights

• i14 — We are i14 — we sit at the intersection of Computational Cognitive Science and AI research, and have developed a new class of models called Laplace Sequence Models that are an order of magnitude faster and more efficient and multiples more accurate than the transformer. We’ve also built a foundation model platform that allows organisations tocreate private, domain-specific expert models deployable across any environment (on-prem, at the edge, on device, in a private cloud, or hosted by i14). Our research lab continues to push beyond many of the limitations of current AI, and has a host of research projects which are continually integrated to update our foundation model platform. We recently closed a $4M initial round and are preparing for the next round.
• Mirugen — Mirugen is a preclinical biotechnology company identifying the optimal set of cellular instructions to ask one cell type to become another.
• Cell Bauhaus — Cell Bauhaus uses mathematical and computer modeling to understand, predict, and modify living cell behavior, aiming to expedite sustainable solutions to humanity's pressing issues.

Portfolio highlights

• S2data — Revolutioniere deine Lieferkette mit intelligenter Logistik. Effiziente Transporte durch bahnbrechende Algorithmen & einzigartige Software.
• Syntropic Medical — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
• Cycuria Therapeutics — While new therapies, such as FLT3 inhibitors and venetoclax-based regimens, have improved initial response rates, durable remissions and long-term survival